Search
Sign In
Sign In
Sources
7 Total Sources
FDA Pauses Regenxbio Gene Therapy Trial After 5 Patients Develop Spinal Masses
Left
25%
Center
50%
Right
25%
All
7
Left
1
Center
2
Right
1
Others
3
STAT
17h ago
FDA Pauses Regenxbio Gene Therapy Trial Over Spinal Masses
Barron's
17h ago
Regenxbio Stock Sinks 25% Following Surprise Finding in Gene Therapy Trial - Barron's
ua.news
17h ago
FDA again halts Regenxbio gene therapy trial over safety concerns | UA.NEWS
Yahoo Finance
5h ago
FDA places clinical hold on Regenxbio's gene therapy for Hunter Syndrome
BioSpace
17h ago
REGENXBIO's Hunter syndrome gene therapy hit by FDA hold, stymieing resubmission plans - BioSpace
StockTitan
17h ago
REGENXBIO: FDA Holds RGX-121 After 5 MRI Findings | RGNX Stock News
PR Newswire
17h ago
REGENXBIO Announces Regulatory Update on RGX-121 for MPS II